What is a stock summary page? Click here for an overview.
Business Description
Avrobio Inc
NAICS : 325414
SIC : 2836
ISIN : US05455M1009
Description
Avrobio Inc is a clinical-stage gene therapy company. The company is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single-dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-03 for the treatment of Pompe disease.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.78 | |||||
| 9-Day RSI | 41.57 | |||||
| 14-Day RSI | 48.82 | |||||
| 6-1 Month Momentum % | 4.51 | |||||
| 12-1 Month Momentum % | 31.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AVRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Avrobio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 8.28 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.43 | ||
| 3-Year Sortino Ratio | -0.62 | ||
| Volatility % | 73.83 | ||
| 14-Day RSI | 48.82 | ||
| 14-Day ATR ($) | 0.721052 | ||
| 20-Day SMA ($) | 17.5008 | ||
| 12-1 Month Momentum % | 31.13 | ||
| 52-Week Range ($) | 10.5612 - 19.8 | ||
| Shares Outstanding (Mil) | 3.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Avrobio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Avrobio Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Avrobio Inc Frequently Asked Questions
What is Avrobio Inc(AVRO)'s stock price today?
The current price of AVRO is $16.80. The 52 week high of AVRO is $19.80 and 52 week low is $10.56.
When is next earnings date of Avrobio Inc(AVRO)?
The next earnings date of Avrobio Inc(AVRO) is 2025-05-09 Est..
Does Avrobio Inc(AVRO) pay dividends? If so, how much?
Avrobio Inc(AVRO) does not pay dividend.
Guru Commentaries on NAS:AVRO
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers